Henry Schein Stock Price, News & Analysis (NASDAQ:HSIC)

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings or view top-rated stocks.

7 brokers have issued 1-year price targets for Henry Schein's shares. Their HSIC share price targets range from $65.00 to $96.00. On average, they expect the company's share price to reach $79.38 in the next year. This suggests a possible upside of 12.4% from the stock's current price.
View analysts price targets for HSIC or view top-rated stocks among Wall Street analysts.

Henry Schein's stock was trading at $79.87 at the beginning of the year. Since then, HSIC shares have decreased by 11.6% and is now trading at $70.59.
View the best growth stocks for 2023 here.

Henry Schein saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 3,460,000 shares, an increase of 39.0% from the October 31st total of 2,490,000 shares. Based on an average trading volume of 996,600 shares, the days-to-cover ratio is presently 3.5 days. Approximately 2.7% of the shares of the stock are sold short.
View Henry Schein's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our HSIC earnings forecast.

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings data on Monday, November, 13th. The company reported $1.32 earnings per share for the quarter, hitting analysts' consensus estimates of $1.32. The business had revenue of $3.16 billion for the quarter, compared to analysts' expectations of $3.21 billion. Henry Schein had a net margin of 3.51% and a trailing twelve-month return on equity of 16.08%. The company's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 earnings per share.
Read the conference call transcript.

ETFs with the largest weight of Henry Schein (NASDAQ:HSIC) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), American Century Focused Large Cap Value ETF (FLV), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), Invesco S&P 500 Equal Weight Health Care ETF (RYH), First Trust Health Care AlphaDEX Fund (FXH), Invesco ESG NASDAQ Next Gen 100 ETF (QQJG), First Trust Active Factor Mid Cap ETF (AFMC) and IQ Candriam ESG U.S. Mid Cap Equity ETF (IQSM).

Henry Schein shares split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein declared that its board has initiated a stock repurchase program on Thursday, August 18th 2022, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

Henry Schein issued an update on its FY23 earnings guidance on Monday, November, 13th. The company provided earnings per share guidance of $4.43-4.71 for the period, compared to the consensus estimate of $5.20. The company issued revenue guidance of down 1-3% yr/yr to ~$12.27-12.52 billion, compared to the consensus revenue estimate of $12.83 billion.

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Henry Schein's stock is owned by a number of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (3.65%), American Century Companies Inc. (3.61%), Invesco Ltd. (3.36%), Perpetual Ltd (3.28%), Morgan Stanley (1.62%) and Massachusetts Financial Services Co. MA (1.32%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.